Aptar Pharma Files New Patents and Reveals Preclinical Advances in Intranasal and Pulmonary GLP-1 Delivery

Innovative formulations and device technologies aim to enhance systemic delivery of GLP-1 therapies via inhalation and nasal routes

IIPLA News Desk•anonymous access•0 articles left this week

Aptar Pharma Files New Patents and Reveals Preclinical Advances in Intranasal and Pulmonary GLP-1 Delivery

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Aptar Pharma has announced the publication of three international patent applications centered on inhaled and nasal delivery of GLP-1-based biologics. Supported by preclinical pharmacokinetic data demonstrating significant improvements in systemic drug exposure, these filings reflect the company’s strategic expansion…

Share This Article

Ready-to-post copy includes the article link.

Aptar Pharma Files New Patents and Reveals Preclinical Advances in Intranasal and Pulmonary GLP-1 Delivery Aptar Pharma has announced the publication of three international patent applications centered on inhaled and nasal delivery of GLP-1-based biologics. Supported by preclinical pharmacokinetic data demonstrating signific... Read the full IIPLA article: https://iipla.org/news/aptar-pharma-files-new-patents-and-reveals-preclinical-advances-in-intranasal-and-pulmonary-glp-1-delivery

LinkedIn X Facebook WhatsApp Telegram Email

Related Coverage

Continue in the newsroom

Back to newsroom

PatentsUSA

Maryland Allocates $85 Million to Acquire Preakness Stakes and Black-Eyed Susan IP Rights

Maryland is investing $85 million to obtain intellectual property rights for the Preakness Stakes and Black-Eyed Susan, matching a prior bid from Churchill Downs. The acquisition, funded through a tax-exempt bond, aims to protect the state's horseracing legacy and reduce future licensing costs.

Thursday, June 18, 2026

PatentsUSA

Maryland Exercises Right to Match $85 Million Offer for Preakness Stakes Intellectual Property

Maryland has announced its intent to match an $85 million bid by Churchill Downs Inc. to acquire the intellectual property rights of the Preakness Stakes and Black-Eyed Susan Stakes. By exercising its right of first refusal, Maryland aims to retain ownership of these iconic racing assets, ensuring long-term control ov…

Thursday, June 18, 2026

PatentsMiddle East

Saudi Arabia Advances to 13th Globally in 2026 IMD Competitiveness Index, Secures 3rd Among G20 Economies

Saudi Arabia climbed four places to 13th in the 2026 IMD World Competitiveness Yearbook, ranking third among G20 nations. The Kingdom’s improvements span economic performance, government efficiency, business efficiency, and infrastructure, underscoring its sustained economic transformation and reform momentum. Saudi A…

Thursday, June 18, 2026

PatentsMiddle East

Samyang Secures Trademark Rights for ‘Buldak’ Noodle Brand in South Korea

Samyang Foods has successfully registered the trademark for its flagship ‘Buldak’ noodle brand with South Korea’s Ministry of Intellectual Property. This milestone follows a prolonged battle since 2008, overcoming initial refusals due to the term’s generic perception. The registration covers ‘Buldak’ in English for no…

Thursday, June 18, 2026

PatentsUSA

Maryland Moves to Acquire Preakness Stakes Intellectual Property for $85 Million

Maryland Governor Wes Moore announced the state will match Churchill Downs’ $85 million bid to purchase the intellectual property rights to the Preakness Stakes and Black-Eyed Susan Stakes. The acquisition will be financed through 30-year bonds issued by the Maryland Economic Development Corporation, with debt service…

Thursday, June 18, 2026

PatentsUSA

Maryland Moves to Acquire Intellectual Property Rights of Preakness Stakes and Black-Eyed Susan

Maryland Governor Wes Moore announced the state's intent to acquire the intellectual property rights to the Preakness Stakes and Black-Eyed Susan races by matching an $85 million offer from Churchill Downs Inc. The acquisition will be funded through tax-exempt bonds without using General Fund dollars, ensuring that re…

Thursday, June 18, 2026